XBI State Street SPDR S&P Biotech ETF
AMEXETFAs of 2026-10-08 11:12
Why XBI matters now
State Street SPDR S&P Biotech ETF (XBI) is a US etf in Financial Services. The latest InvestLog snapshot shows $146.83 with -2.27% on the session and $7.68B in assets/market value.
The latest indexable market news headline is "SPDR S&P Biotech ETF XBI Stock Acquired by Ayalon Insurance Comp Ltd." from Defense World.
ETF Profile
Updated 2026-10-08Net Assets
$10.08B
NAV
$150.89
Expense Ratio
0.35%
Holdings
165
Issuer
SPDR
Asset Class
Equity
Avg Volume
9,019,609
Inception
2006-01-31
Sector Exposure
Top Holdings
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| MRNA | MODERNA INC | 2.07% | $213.9M |
| TWST | TWIST BIOSCIENCE CORP | 2.00% | $205.9M |
| NTRA | NATERA INC | 1.82% | $187.7M |
| UTHR | UNITED THERAPEUTICS CORP | 1.60% | $165.4M |
| ABBV | ABBVIE INC | 1.60% | $164.5M |
| BIIB | BIOGEN INC | 1.59% | $163.7M |
| AMGN | AMGEN INC | 1.54% | $159.3M |
| HALO | HALOZYME THERAPEUTICS INC | 1.53% | $158.1M |
| EXEL | EXELIXIS INC | 1.50% | $154.8M |
| CRSP | CRISPR THERAPEUTICS AG | 1.49% | $153.6M |
Latest News
Fund Info
Asset Type
ETF
Exchange
AMEX
Currency
USD
Issuer
SPDR
Asset Class
Equity
NAV Currency
USD
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.